Virtus Lifesci Biotech Etf Performance

BBP Etf  USD 58.48  1.38  2.42%   
The entity has a beta of 0.89, which indicates possible diversification benefits within a given portfolio. Virtus LifeSci returns are very sensitive to returns on the market. As the market goes up or down, Virtus LifeSci is expected to follow.

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Virtus LifeSci Biotech are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable fundamental drivers, Virtus LifeSci is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors. ...more
1
Baton Rouge Automation Manufacturer to Expand Headquarters
04/03/2024
In Threey Sharp Ratio0.09
  

Virtus LifeSci Relative Risk vs. Return Landscape

If you would invest  5,582  in Virtus LifeSci Biotech on March 24, 2024 and sell it today you would earn a total of  266.00  from holding Virtus LifeSci Biotech or generate 4.77% return on investment over 90 days. Virtus LifeSci Biotech is generating 0.0826% of daily returns assuming volatility of 1.2328% on return distribution over 90 days investment horizon. In other words, 10% of etfs are less volatile than Virtus, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon Virtus LifeSci is expected to generate 1.87 times more return on investment than the market. However, the company is 1.87 times more volatile than its market benchmark. It trades about 0.07 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.01 per unit of risk.

Virtus LifeSci Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Virtus LifeSci's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as Virtus LifeSci Biotech, and traders can use it to determine the average amount a Virtus LifeSci's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.067

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashBBPAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 1.23
  actual daily
10
90% of assets are more volatile

Expected Return

 0.08
  actual daily
1
99% of assets have higher returns

Risk-Adjusted Return

 0.07
  actual daily
5
95% of assets perform better
Based on monthly moving average Virtus LifeSci is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Virtus LifeSci by adding it to a well-diversified portfolio.

Virtus LifeSci Fundamentals Growth

Virtus Etf prices reflect investors' perceptions of the future prospects and financial health of Virtus LifeSci, and Virtus LifeSci fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Virtus Etf performance.

About Virtus LifeSci Performance

To evaluate Virtus LifeSci Biotech Etf as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Virtus LifeSci generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Virtus Etf's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Virtus LifeSci Biotech market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Virtus's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Under normal market conditions, the fund will invest not less than 80 percent of its assets in component securities of the index. Virtus Lifesci is traded on NYSEARCA Exchange in the United States.
The fund holds 98.73% of its assets under management (AUM) in equities

Additional Information and Resources on Investing in Virtus Etf

When determining whether Virtus LifeSci Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Virtus Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Virtus Lifesci Biotech Etf. Highlighted below are key reports to facilitate an investment decision about Virtus Lifesci Biotech Etf:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Virtus LifeSci Biotech. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine if Virtus LifeSci is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.